IL6 and neoplasm: The administration of arjunolic acid in this study led to a significant reduction in pro‐inflammatory cytokines such as TNF‐α, IFN‐γ, and IL‐6, along with lower levels of VEGF (a key factor in tumor angiogenesis) and a marked increase in anti‐inflammatory cytokine IL‐10.